A new study conducted by researchers at Penn Dental Medicine found a potential therapy to fight against periodontal diseases.
The translation study targeted senescent cell burden as an effective strategy to managing periodontal disease and improving oral health, according to an April 11 news release from Penn Dental Medicine.
Sensotherapy targets inflammation and senescent cells, disrupting the chronic disease cycle. These therapies eliminate senescent cells or reduce their harmful effects.
In their new study, researchers used the dasatinib-quercetin combination, a senotherapy that has shown an ability to reduce senescent cell numbers and senescence markers in other clinical contexts.
Periodontal diseases, such as gingivitis and periodontitis, affect nearly 60% of adults aged 65 and older, the release said.